Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Vet Microbiol ; 142(3-4): 367-72, 2010 May 19.
Artigo em Inglês | MEDLINE | ID: mdl-19914012

RESUMO

Elk in the Greater Yellowstone Area are a major reservoir for brucellosis, which represents an obstacle to eradication of the disease in domestic livestock. Furthermore, immune responses to Brucella abortus infection in the wild host are not well-understood. In this regard, in vivo-induced antigen technology (IVIAT) was employed to identify novel B. abortus antigens expressed during infection in elk. Sera collected from sero-positive Wyoming elk were pooled and absorbed against in vitro-grown cultures of B. abortus. Approximately 35,000 E. coli clones, expressing B. abortus DNA, were then screened by colony immunoblot, yielding ten genes with immuno-reactive products, to include seven proteins secreted beyond the inner membrane. Three products, an outer membrane protein (D15), malate dehydrogenase (Mdh), and an ion transporter (AfuA), were examined by Western blot against individual elk serum samples. Sero-reactivity was significantly more frequent for both Mdh and D15 in naturally infected animals, compared to vaccinated and uninfected elk, indicating that antibody to these two antigens is a predictor of natural infection. Cross-reactivity of all three proteins was next examined with serum samples from confirmed brucellosis-positive cattle. While variable patterns of reactivity were seen with the antigens, the sample group was equivalently reactive to AfuA and Mdh, compared to elk, suggesting that these antigens are commonly expressed during infection in both hosts. We conclude that the application of IVIAT to B. abortus may not only facilitate the identification of serologic markers for brucellosis in elk, but may provide further insight into biological processes of the pathogen in different hosts.


Assuntos
Brucella abortus/genética , Brucelose/veterinária , Cervos/microbiologia , Genes Bacterianos/genética , Técnicas Imunológicas/veterinária , Animais , Antígenos de Bactérias/imunologia , Biomarcadores/sangue , Western Blotting , Brucella abortus/imunologia , Brucelose/imunologia , Brucelose/microbiologia , Reações Cruzadas , Cervos/imunologia , Wyoming
2.
Ross Fiziol Zh Im I M Sechenova ; 95(12): 1416-26, 2009 Dec.
Artigo em Russo | MEDLINE | ID: mdl-20141051

RESUMO

Adaptive-transfer experimental autoimmune encephalomyelitis is an inflammatory neurodegenerative disease which is induced by injection of activated encephalitogenic T cells. Adaptive-transfer experimental autoimmune encephalomyelitis is a major experimental tool for investigation ofT cell function in multiple sclerosis development. Activated myelin basic protein specific T cells are able to invade and inflame the central nervous system which is followed by axonal injury and paralysis on the third day after injection. In the prodromal phase of EAE encephalitic T cells migrate through different organs which alter their phenotype before invading the CNS. We compared migratory patterns of encephalitic T cells after intravenous and intraperitoneal injection to elucidate which organs may play an important role in the formation of "migratory" phenotype. We found that encephalitogenic T cells ultimately migrate through spleen and parathymic lymph nodes regardless of the start point of cells migration after i.p. and i.v. injection. We hypothesise that cellular and extracellular components of these organs could be involved in the formation of T cells "migratory" phenotype which is necessary for penetration via blood-brain barrier.


Assuntos
Movimento Celular/imunologia , Sistema Nervoso Central/imunologia , Encefalomielite Autoimune Experimental/imunologia , Transfusão de Linfócitos , Linfócitos T/imunologia , Transferência Adotiva , Animais , Sistema Nervoso Central/patologia , Encefalomielite Autoimune Experimental/patologia , Ratos , Ratos Endogâmicos Lew , Linfócitos T/patologia
3.
Int J Cardiol ; 122(2): 125-30, 2007 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-17222927

RESUMO

BACKGROUND: Peak oxygen uptake (pVO2) is used for risk stratification in chronic heart failure (CHF), but little is known about the prognostic impact of pVO2-changes in patients on chronic beta-blocker (BBL) therapy. We therefore prospectively evaluated individual pVO2-changes at a 6-month interval in patients all receiving BBL. METHODS: 194 patients with stable CHF on stable medication were included (V1) and underwent clinical evaluation and exercise testing. Testing was repeated (V2) at 5.7+/-1.5 months after V1 and patients were followed >12 months after V2. Death or hospitalisation due to cardiac reasons was the predefined EP (EPP, end-point positive; n=62; EPN, end-point negative; n=113). RESULTS: Initial characteristics did not differ between EPP and EPN. Multivariate cox regression analysis revealed that change of pVO2 (EPP: -0.6+/-2.6 ml/kg min; EPN: +2.5+/-3.3 ml/kg min; p<0.001) was independent to pVO2, LVEF, NTproBNP and NYHA at V2 for prediction of the combined end-point during follow-up. An increase of pVO2 by 10% was identified as an adequate cut-off value for risk stratification and ROC-analysis showed the significant incremental prognostic value of the determination of pVO2 changes in combination with pVO2. CONCLUSIONS: Serial measurements of pVO2 yield additional information for risk stratification in clinically homogenous CHF patients receiving BBL. This is the first study demonstrating this fact within a narrow predefined interval with all patients on BBL.


Assuntos
Insuficiência Cardíaca/tratamento farmacológico , Insuficiência Cardíaca/fisiopatologia , Consumo de Oxigênio , Adulto , Distribuição de Qui-Quadrado , Progressão da Doença , Teste de Esforço , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Prognóstico , Estudos Prospectivos , Curva ROC , Medição de Risco
4.
Osteoporos Int ; 13(6): 480-6, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12107662

RESUMO

The demographic changes in the human population continue to lead to an increasing incidence of osteoporosis. The main clinical symptom of osteoporosis is fracture. Fracture fixation in osteoporosis is frequently complicated by failure of fixation. There is a great need for a large-animal model of osteoporosis for controlled studies, which allows the investigation of fracture healing and fracture treatment in weak bone. Eight swiss mountain sheep, 7-9 years old, were divided into four treatment groups of two animals each. Group 1 was ovariectomized and fed a calcium/vitamin D-restricted diet (O+D). Group 2 was ovariectomized and given a daily intramuscular injection of 25 mg methylprednisolone (O+S). Group 3 was ovariectomized, fed a calcium/vitamin D-restricted diet and injected with 25 mg intramuscular methylprednisolone per day (O+D+S). Group 4 was used as an untreated, not sham operated control group. At the beginning of the study and every 2 months for 6 months the bone mineral density (BMD) was determined using quantitative computed tomography (pQCT) at the distal radius. Biopsies were taken after 6 months from vertebral bodies and femoral heads and the bone structure, i.e. trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), bone surface fraction (BS/BV) and bone volume fraction (BV/TV), was determined by micro-CT. In vitro compression testing of the biopsies was performed to determine failure load and stiffness. The control group showed no changes in BMD. The greatest decrease in BMD was seen in group 3 (O+D+S), which had a decline of 58% in cancellous bone and 22% in cortical bone. In the vertebral body biopsies a prominent change in structural parameters was observed (Tb.N, -53%; Tb.Th, -63%, Tb.Sp, +150%). The changes were less pronounced in the femoral head biopsies. In the compression test the vertebral body biopsies of group 3 (O+D+S) had stiffness values 40% lower failure load 70% lower compared with the control group. The most effective method of inducing osteoporosis in sheep was found to be the combined treatment. These results need to be confirmed in a larger number of animals.


Assuntos
Osso e Ossos/fisiopatologia , Modelos Animais , Ovinos , Idoso , Animais , Densidade Óssea/efeitos dos fármacos , Cálcio/deficiência , Feminino , Fraturas Ósseas/etiologia , Fraturas Ósseas/terapia , Glucocorticoides , Humanos , Metilprednisolona , Pessoa de Meia-Idade , Distúrbios Nutricionais/fisiopatologia , Osteoporose Pós-Menopausa/etiologia , Osteoporose Pós-Menopausa/fisiopatologia , Ovariectomia , Projetos Piloto , Deficiência de Vitamina D/fisiopatologia
5.
J Orthop Trauma ; 14(8): 559-65; discussion 565-6, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11149502

RESUMO

OBJECTIVE: Various regimens to induce osteoporosis in sheep were compared to establish a large animal model for further studies of fracture healing and fracture treatment in severe osteoporosis. DESIGN: Prospective, randomized animal study (six months' duration). PARTICIPANTS: Eight sheep (seven to nine years old) were divided into four treatment groups of two animals each. INTERVENTION: Group 1: Ovariectomy (OVX) + calcium/vitamin D-restricted diet (O + D); Group 2: Ovariectomy + daily injection of steroids (O + S); Group 3: Ovariectomy + daily injection of steroids + calcium/vitamin D-restricted diet (O + D + S); Group 4: Control, untreated. MAIN OUTCOME MEASUREMENTS: Preoperatively and every 2 months, the bone mineral density (BMD) was determined by quantitative computed tomography (QCT) bilaterally at the distal tibia. Bone structural parameters were determined from iliac crest biopsy specimens using micro-CT. In vitro torsional stiffness of tibia segments was measured. RESULTS: The control group showed a slight increase in BMD with time. The greatest decrease in BMD was seen in Group 3, with a decrease of 55 percent in cancellous bone and 7 percent in cortical bone. In the iliac crest biopsy specimens, trabecular number decreased 19 percent, trabecular thickness decreased 22 percent, and bone volume fraction decrased 37 percent during the 6 months. The torsional strength and stiffness of the tibia showed a difference of approximately 50 percent between Group 3 and the control group. CONCLUSIONS: The induction of severe osteoporosis in sheep is best possible by combined treatment with ovariectomy, calcium/vitamin D-restricted diet, and steroids. There is a good relationship between density, structural parameters, and mechanical properties of bone.


Assuntos
Modelos Animais de Doenças , Fraturas Espontâneas/etiologia , Osteoporose/induzido quimicamente , Osteoporose/complicações , Ovariectomia/métodos , Absorciometria de Fóton , Animais , Densidade Óssea/fisiologia , Regeneração Óssea , Compostos de Cálcio , Terapia Combinada , Dieta , Feminino , Fraturas Espontâneas/terapia , Ílio/diagnóstico por imagem , Masculino , Osteoporose/diagnóstico , Osteoporose/terapia , Projetos Piloto , Estudos Prospectivos , Distribuição Aleatória , Valores de Referência , Ovinos , Esteroides , Resultado do Tratamento , Vitamina D
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA